Mark L. Pacala - 17 Nov 2022 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
By: Mark Hueppelsheuser For: Mark Pacala
Issuer symbol
TOI
Transactions as of
17 Nov 2022
Net transactions value
$0
Form type
4
Filing time
21 Nov 2022, 16:34:18 UTC
Previous filing
23 Sep 2022
Next filing
21 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Award $0 +2,160 +4.3% $0.000000 52,780 17 Nov 2022 Direct
transaction TOI Common Stock Award $0 +29,057 +55% $0.000000 81,837 17 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in full on May 17, 2023, subject to continued service with the Company through such vesting date.